Skip to content

Evaluation of the Fortilink IBF System With TETRAfuse Technology

Evaluation of the Fortilink IBF System With TETRAfuse Technology

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03699891
Acronym
ENTRUST
Enrollment
119
Registered
2018-10-09
Start date
2018-11-06
Completion date
2019-01-15
Last updated
2019-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical and Lumbar Fusion

Brief summary

This is a multi-center, post-market, retrospective study to collect safety and performance data for patients implanted with the Fortilink IBF System.

Detailed description

This is a multi-center, post-market, retrospective study to collect safety and performance data for patients implanted with the Fortilink IBF System. The study will include up to 110 patients at up to 8 US sites. All patients implanted with the Fortilink System at a site will be included in the data collection. The goal is to collect data for at least 100 subjects, but the sample size will be capped at 110 to ensure that all patients at a given site are included in the analysis.

Interventions

Cervical and lumbar fusion

Sponsors

RTI Surgical
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patient must have had an attempted implant of the Fortilink IBF System

Exclusion criteria

* There are no

Design outcomes

Primary

MeasureTime frameDescription
Safety outcomes associated with use of the Fortlink SystemUp to 1 yearSafety assessment includes evaluation of all adverse events or complications related to the procedure and post-operative adverse events.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026